Welcome to Blood Cancer United Newsroom
Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.
Professional Education Webcasts
Empoderando a los Promotores de Salud: Una Serie Educativa sobre los Cánceres de la Sangre
Estos videos en español están diseñados para fortalecer el conocimiento de los Promotores de Salud y conectar a las comunidades hispanas y latinas con…
Patient Education Webcasts
What’s Next on the Roadmap: Finding Primary Care
Join us for a panel discussion on transitioning to primary care after a cancer diagnosis. Transitioning from the oncologist to a primary care provider…
Research
BioInvent Receives FDA Orphan Drug Designation for BI-1808 for the Treatment of T-cell Lymphoma
Lund, Sweden – March 20, 2025 – BioInvent International AB (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and development of nov…
Research
Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline
Paris, March 20, 2025. Sanofi and Dren Bio, Inc., a private clinical-stage biopharmaceutical company, have entered into a definitive agreement under w…
Patient Education Webcasts
The Future of Myeloma Treatment: What’s Next?
Patient Education Videos
CAR T-Cell Therapy: A Path of Hope and Healing
This new docuseries informs blood cancer patients, caregivers, healthcare providers, and the public about the revolutionary progress of CAR T-cell the…
Professional Education Webcasts
Introducción al cáncer de la sangre: Aspectos básicos sobre la enfermedad, el tratamiento y el rol del profesional médico
This is the Spanish translation of Blood Cancer 101: The Basics on Disease, Treatment, and the Role of the HCP.Para trabajadores sociales, enfermeros …
Research
Kura Oncology and Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial and Positive FDA Feedback for Upcoming Frontline Combination Trial Designs
SAN DIEGO, Feb. 05, 2025 - Kura Oncology, Inc. and Kyowa Kirin Co., Ltd. today announced positive topline results from KOMET-001, the Phase 2 registra…
Research
BioInvent announces promising initial efficacy data from triple combination arm of BI-1206, rituximab and Calquence for the treatment of non-Hodgkin's lymphoma
Lund, Sweden – January 8, 2025 – BioInvent International AB (“BioInvent”) (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and dev…
Patient Education Webcasts
Cafecito con LLS: Hablemos de Abogacía Legal y Atención Medica
Únase a la conversación donde conocemos a Melanie Grant Esq, abogada de Triage Cancer® defensora jurídica de los derechos de salud para aquellos padec…
For all media-related inquiries and interview requests please email
mediarelations@bloodcancerunited.org
A Blood Cancer United representative will respond as soon as possible.
